Buy Merck & Co., Inc. Stocks - View MRK Live Price (2026)

MRK

TYPE Stocks

GROUP Stocks

BASE Merck & Co.,...

SECOND

<% (signals.list.current.rate).substr(0,7) %>

<% (signals.list.current.absolute).substr(0,9) %> (<% signals.list.current.percentage|toFixed:2 %>%)

MARKETS TREND

OPEN

<% (signals.list.current.openrate).substr(0,9) %>

HIGH

<% (signals.list.current.high).substr(0,9) %>

LOW

<% (signals.list.current.low).substr(0,9) %>

START TRADING

Multi Charts

Add to Watchlist

MRK Signals

DON'T WANT TO MISS ANY SIGNAL? GO PREMIUM

ACCESS ALL FX, COMMODITIES & CRYPTO SIGNALS. GO PREMIUM

<% signal.pair %> (<% signal.rate %>) <% signal.action %>

<% signal.status %>

<% signal.analyst %>

Long Term

Entry Price

Stop Loss

Take Profit

<% signal.entryPrice %> N/A

PREMIUM ONLY

<% signal.stopLoss %> N/A

PREMIUM ONLY

<% signal.takeProfit %> N/A

PREMIUM ONLY

<% signal.comment %>

Description

<% signal.description %>

LATEST ANALYSIS

<% item.time_ago %> Ago

<% item.title %>

<% item.deltaTime %>

Full Analysis Feed

Last Updated: May 04, 2026 03:30:04 PM (GMT)

MRK: The current live price is 63.11, with no percentage change available from the previous price.

Support and Resistance Levels The current support levels are 63.11, 63.11, and 63.11. The resistance levels are also 63.11, 63.11, and 63.11. The pivot point is 63.11.

Indicators The RSI is currently at 100, indicating a strong overbought condition with no changes in its trend. The ATR is 0, suggesting minimal volatility. The Parabolic SAR is at 63.11, having remained unchanged. The 5-day SMA and EMA are both at 63.11, consistent with the price level.

Market Sentiment Market sentiment is bearish, as the price is at the pivot point (63.11), with indicators suggesting overbought conditions.

About (mrk) Merck & Co., Inc.

Company Background

Merck & Co., Inc. (NYSE: MRK) is a global healthcare leader that is committed to enhancing the lives of patients through innovative medicines, vaccines, and animal health products. Founded in 1891, Merck has a rich history of scientific breakthroughs and advancements in drug development. Headquartered in Kenilworth, New Jersey, the company operates in over 140 countries, employing more than 70,000 people worldwide. Merck is known for its dedication to research and development, allocating significant resources to discovery and innovation in various therapeutic areas, including oncology, infectious diseases, diabetes, and cardiovascular health.

Market Position

Merck holds a prominent position in the global pharmaceutical industry, consistently ranking among the top companies by revenue and market capitalization. The company has successfully developed a diverse portfolio of products that cater to a wide range of medical needs. Notably, Merck's cancer immunotherapy drug, Keytruda, has established itself as a leading therapy for various types of cancer, driving significant revenue growth and solidifying the company's reputation as a pioneer in oncology. In addition to oncology, Merck is also a leader in vaccine development, particularly with its Gardasil vaccine, which protects against HPV-related cancers and diseases.

Key Financial and Industry Highlights

In recent years, Merck has consistently reported strong financial performance, with increasing revenues and robust profit margins. For the fiscal year ending 2022, the company recorded revenues exceeding $60 billion, showcasing strong growth driven by its innovative product pipeline. Merck's commitment to sustainability and corporate responsibility further enhances its market position, as the company continues to prioritize environmental stewardship and access to healthcare. With a strong focus on pipeline expansion and strategic acquisitions, Merck is well-positioned for future growth in an evolving healthcare landscape. The company's focus on innovation and its strong financial foundation make it a compelling choice for investors looking for stability and growth in the biopharmaceutical space.

Check all MRK conversion rates